Department of Hematology, Faculty of Medicine, Yuzuncu Yil University, Van, Turkey.
Clin Appl Thromb Hemost. 2011 Nov-Dec;17(6):E114-8. doi: 10.1177/1076029610387588. Epub 2010 Dec 15.
We investigated the prevalence of antinuclear antibody (ANA), thyroid antimicrosomal (AMA) and antithyroglobulin (ATA), antigliadin (AGA) immunoglobulin G (IgG)-A, anti-endomisium (EMA) IgG-A, and tissue transglutaminase (tTG) IgG-A in 87 patients with chronic idiopathic thrombocytopenic purpura (cITP) and in 95 healthy controls. Antinuclear antibody positivity was found in 13 of 87 patients and 3 of 95 controls (P = .007). Antithyroglobulin positivity was found in 27 of patients and in 7 of the controls (P < .001). AMA positivity was found in 20 of patients and 8 of the controls (P = 0.008). Antigliadin IgG was positive in 17 patients and 1 controls (P < .001) whereas Antigliadin IgA was positive in 9 of patients and in 1 of the controls (P = .007). Anti-endomisium (IgG and IgA were not different between both groups. Tissue transglutaminase IgG was detected in 7 of patients and in 1 of the controls (P = .029). Tissue transglutaminase IgA was detected in 5 of patients and in none of the controls (P = .023). We believe that larger studies are needed to determine the long-term impact and clinical importance of these autoantibodies.
我们调查了 87 例慢性特发性血小板减少性紫癜(cITP)患者和 95 名健康对照者的抗核抗体(ANA)、甲状腺抗微粒体(AMA)和抗甲状腺球蛋白(ATA)、抗麦胶蛋白(AGA)免疫球蛋白 G(IgG)-A、抗肌内膜(EMA)IgG-A 和组织转谷氨酰胺酶(tTG)IgG-A 的患病率。在 87 例患者中有 13 例和 95 例对照者中 3 例ANA 阳性(P =.007)。在 27 例患者中有抗甲状腺球蛋白阳性和在 7 例对照者中阳性(P <.001)。在 20 例患者中有 AMA 阳性和在 8 例对照者中阳性(P = 0.008)。抗麦胶蛋白 IgG 在 17 例患者中有阳性和在 1 例对照者中有阳性(P <.001),而抗麦胶蛋白 IgA 在 9 例患者中有阳性和在 1 例对照者中有阳性(P =.007)。抗肌内膜(IgG 和 IgA 在两组之间没有差异。组织转谷氨酰胺酶 IgG 在 7 例患者中有阳性和在 1 例对照者中有阳性(P =.029)。组织转谷氨酰胺酶 IgA 在 5 例患者中有阳性和在 95 例对照者中无阳性(P =.023)。我们认为需要进行更大规模的研究来确定这些自身抗体的长期影响和临床重要性。